A study published in late August found that 345 people in England died of myocarditis in one year, all vaccinated with one of three COVID-19 vaccines.
The study, conducted from December 2020 to December 2021, looked at deaths after a hospital stay for myocarditis or with myocarditis listed as a cause of death on a death certificate among 42.8 million vaccinated people in England aged 13 and older.
“This is really big, to talk about deaths. CDC [Centers for Disease Control and Prevention] keeps saying, ‘generally mild, generally mild,’” cardiologist Sanjay Verma, who wasn’t involved in the research, told The Epoch Times. “There’s been a concerted campaign to emphasize that people have not died from myocarditis and that it’s generally mild.”
Myocarditis is defined as inflammation of the myocardium, the middle layer of the heart muscle. Although the CDC has acknowledged since the spring of 2021 that myocarditis is a possible side effect of the Pfizer-BioNTech and Moderna vaccines, the agency hasn’t publicly spoken about death as a possible outcome of myocarditis.
The authors of the study reviewed patient data pulled from the national health database for all those in England aged 13 and older who received at least one dose of one of three vaccines available in the country: AstraZeneca, Pfizer-BioNTech, and Moderna.
About 20 million people got the AstraZeneca vaccine, 20 million got the Pfizer vaccine, and more than 1 million got the Moderna vaccine.
The study tracked hospital admissions and deaths from myocarditis by age and gender and in relation to how many doses of each vaccine a person had received. It compared how many cases of myocarditis were associated with a recent SARS-CoV2 infection and how many were associated with one of the vaccines.
Of the people who received the Pfizer-BioNTech vaccine and were hospitalized for myocarditis or with myocarditis listed on their death certificates, 22 people (17 percent) died within 28 days of receiving the first dose, 14 people (12 percent) died after their second dose, and 13 people (15 percent) died after getting the Pfizer-BioNTech booster.
For the AstraZeneca vaccine, 40 people died of myocarditis after the first dose and 11 after the second dose, amounting to 28 percent and 12 percent respectively.
Among those who got the Moderna vaccine, there were no myocarditis deaths within 28 days of vaccination.
The study concluded that, in general, the risk of myocarditis from SARS-CoV2, the virus that causes COVID-19, was greater than the risk of myocarditis from the vaccines. But there was no control group of unvaccinated people, the study was limited to the 28 days following vaccination, and the conclusion didn’t hold for all ages or all the vaccines.
For males younger than 40, the risk of myocarditis after a second dose of the Moderna vaccine was almost four times higher than the risk of myocarditis after a SARS-CoV2 infection, the data show.
The study is a follow-up to a prior study in which the authors reported an association between the first and second doses of the vaccines and myocarditis.
Neither the CDC nor the Food and Drug Administration has ever acknowledged that any American has died from myocarditis caused by one of the COVID-19 vaccines.
But there’s no mention of death as a possible outcome.
“Most patients with myocarditis or pericarditis after COVID-19 vaccination responded well to medicine and rest and felt better quickly,” the advisory reads.
“One death was reported; investigation is ongoing, and other contributory factors for myocarditis are being evaluated,” the report reads.
The JAMA study alluded to deaths without confirming any, saying that among people younger than 30, there were “no confirmed cases of myocarditis in those who died after mRNA-based COVID-19 vaccination without another identifiable cause” and that two other deaths “with potential myocarditis” are under investigation.